nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—HTR1D—migraine	0.236	0.485	CbGaD
Naratriptan—HTR1B—migraine	0.14	0.288	CbGaD
Naratriptan—HTR1A—migraine	0.111	0.228	CbGaD
Naratriptan—HTR1B—Propranolol—migraine	0.07	0.254	CbGbCtD
Naratriptan—HTR1D—Amitriptyline—migraine	0.0631	0.229	CbGbCtD
Naratriptan—HTR1B—Amitriptyline—migraine	0.0605	0.22	CbGbCtD
Naratriptan—HTR1A—Propranolol—migraine	0.0438	0.159	CbGbCtD
Naratriptan—HTR1A—Amitriptyline—migraine	0.0379	0.138	CbGbCtD
Naratriptan—HTR1B—trigeminal nucleus—migraine	0.00946	0.148	CbGeAlD
Naratriptan—HTR1D—trigeminal nucleus—migraine	0.00916	0.144	CbGeAlD
Naratriptan—HTR1D—meninx—migraine	0.00608	0.0954	CbGeAlD
Naratriptan—HTR1F—trigeminal nerve—migraine	0.00606	0.0951	CbGeAlD
Naratriptan—HTR1B—dura mater—migraine	0.00578	0.0906	CbGeAlD
Naratriptan—HTR1D—dura mater—migraine	0.00559	0.0878	CbGeAlD
Naratriptan—HTR1B—trigeminal nerve—migraine	0.00248	0.039	CbGeAlD
Naratriptan—HTR1D—trigeminal nerve—migraine	0.0024	0.0377	CbGeAlD
Naratriptan—MAOA—locus ceruleus—migraine	0.00224	0.0351	CbGeAlD
Naratriptan—HTR1B—cranial nerve—migraine	0.00177	0.0278	CbGeAlD
Naratriptan—HTR1D—cranial nerve—migraine	0.00171	0.0269	CbGeAlD
Naratriptan—HTR1B—blood vessel—migraine	0.000712	0.0112	CbGeAlD
Naratriptan—HTR1D—blood vessel—migraine	0.00069	0.0108	CbGeAlD
Naratriptan—MAOA—nerve—migraine	0.000669	0.0105	CbGeAlD
Naratriptan—Almotriptan—HTR1D—migraine	0.00059	0.135	CrCbGaD
Naratriptan—Sumatriptan—HTR3A—migraine	0.000574	0.131	CrCbGaD
Naratriptan—Sumatriptan—HTR1D—migraine	0.000568	0.13	CrCbGaD
Naratriptan—HTR1F—head—migraine	0.000525	0.00824	CbGeAlD
Naratriptan—HTR1F—nervous system—migraine	0.000498	0.00781	CbGeAlD
Naratriptan—HTR1F—central nervous system—migraine	0.000479	0.00752	CbGeAlD
Naratriptan—Eletriptan—HTR1D—migraine	0.00046	0.105	CrCbGaD
Naratriptan—Eletriptan—HTR2B—migraine	0.000455	0.104	CrCbGaD
Naratriptan—HTR1B—trigeminal ganglion—migraine	0.00044	0.0069	CbGeAlD
Naratriptan—HTR1D—trigeminal ganglion—migraine	0.000426	0.00668	CbGeAlD
Naratriptan—HTR1B—brainstem—migraine	0.000389	0.00611	CbGeAlD
Naratriptan—HTR1F—brain—migraine	0.000381	0.00597	CbGeAlD
Naratriptan—HTR1D—brainstem—migraine	0.000377	0.00591	CbGeAlD
Naratriptan—MAOA—neck—migraine	0.000376	0.00589	CbGeAlD
Naratriptan—Almotriptan—HTR1B—migraine	0.00035	0.0801	CrCbGaD
Naratriptan—Sumatriptan—HTR1B—migraine	0.000337	0.0771	CrCbGaD
Naratriptan—MAOA—trigeminal ganglion—migraine	0.000324	0.00509	CbGeAlD
Naratriptan—HTR1B—cardiovascular system—migraine	0.000318	0.00499	CbGeAlD
Naratriptan—HTR1A—brainstem—migraine	0.000314	0.00493	CbGeAlD
Naratriptan—HTR1D—cardiovascular system—migraine	0.000308	0.00483	CbGeAlD
Naratriptan—MAOA—brainstem—migraine	0.000287	0.0045	CbGeAlD
Naratriptan—Eletriptan—HTR7—migraine	0.000281	0.0644	CrCbGaD
Naratriptan—Eletriptan—HTR1B—migraine	0.000273	0.0624	CrCbGaD
Naratriptan—Sumatriptan—HTR1A—migraine	0.000267	0.061	CrCbGaD
Naratriptan—HTR1A—cardiovascular system—migraine	0.000256	0.00402	CbGeAlD
Naratriptan—MAOA—cardiovascular system—migraine	0.000234	0.00368	CbGeAlD
Naratriptan—Eletriptan—HTR1A—migraine	0.000216	0.0494	CrCbGaD
Naratriptan—HTR1B—head—migraine	0.000215	0.00338	CbGeAlD
Naratriptan—HTR1D—head—migraine	0.000208	0.00327	CbGeAlD
Naratriptan—HTR1B—nervous system—migraine	0.000204	0.0032	CbGeAlD
Naratriptan—HTR1D—nervous system—migraine	0.000198	0.0031	CbGeAlD
Naratriptan—HTR1B—central nervous system—migraine	0.000196	0.00308	CbGeAlD
Naratriptan—HTR1D—central nervous system—migraine	0.00019	0.00298	CbGeAlD
Naratriptan—HTR1A—head—migraine	0.000174	0.00272	CbGeAlD
Naratriptan—HTR1A—nervous system—migraine	0.000165	0.00258	CbGeAlD
Naratriptan—MAOA—head—migraine	0.000159	0.00249	CbGeAlD
Naratriptan—HTR1A—central nervous system—migraine	0.000158	0.00249	CbGeAlD
Naratriptan—HTR1B—brain—migraine	0.000156	0.00245	CbGeAlD
Naratriptan—HTR1A—cerebellum—migraine	0.000155	0.00243	CbGeAlD
Naratriptan—HTR1D—brain—migraine	0.000151	0.00237	CbGeAlD
Naratriptan—MAOA—nervous system—migraine	0.00015	0.00236	CbGeAlD
Naratriptan—MAOA—central nervous system—migraine	0.000145	0.00227	CbGeAlD
Naratriptan—MAOA—cerebellum—migraine	0.000142	0.00222	CbGeAlD
Naratriptan—HTR1A—brain—migraine	0.000126	0.00197	CbGeAlD
Naratriptan—MAOA—brain—migraine	0.000115	0.0018	CbGeAlD
Naratriptan—Fatigue—Verapamil—migraine	0.000111	0.00116	CcSEcCtD
Naratriptan—Body temperature increased—Propranolol—migraine	0.000111	0.00116	CcSEcCtD
Naratriptan—Pain—Verapamil—migraine	0.00011	0.00115	CcSEcCtD
Naratriptan—Constipation—Verapamil—migraine	0.00011	0.00115	CcSEcCtD
Naratriptan—Vomiting—Amitriptyline—migraine	0.000109	0.00115	CcSEcCtD
Naratriptan—Angina pectoris—Topiramate—migraine	0.000109	0.00114	CcSEcCtD
Naratriptan—Bradycardia—Gabapentin—migraine	0.000108	0.00114	CcSEcCtD
Naratriptan—Rash—Amitriptyline—migraine	0.000108	0.00114	CcSEcCtD
Naratriptan—Dermatitis—Amitriptyline—migraine	0.000108	0.00114	CcSEcCtD
Naratriptan—Headache—Amitriptyline—migraine	0.000108	0.00113	CcSEcCtD
Naratriptan—Bronchitis—Topiramate—migraine	0.000108	0.00113	CcSEcCtD
Naratriptan—Muscle spasms—Valproic Acid—migraine	0.000108	0.00113	CcSEcCtD
Naratriptan—Abdominal discomfort—Topiramate—migraine	0.000107	0.00113	CcSEcCtD
Naratriptan—Tinnitus—Timolol—migraine	0.000107	0.00112	CcSEcCtD
Naratriptan—Haemorrhage—Gabapentin—migraine	0.000107	0.00112	CcSEcCtD
Naratriptan—Cardiac disorder—Timolol—migraine	0.000106	0.00111	CcSEcCtD
Naratriptan—Feeling abnormal—Verapamil—migraine	0.000106	0.00111	CcSEcCtD
Naratriptan—Hypoaesthesia—Gabapentin—migraine	0.000106	0.00111	CcSEcCtD
Naratriptan—Hallucination—Gabapentin—migraine	0.000106	0.00111	CcSEcCtD
Naratriptan—Vision blurred—Valproic Acid—migraine	0.000105	0.00111	CcSEcCtD
Naratriptan—Tremor—Valproic Acid—migraine	0.000105	0.0011	CcSEcCtD
Naratriptan—Ill-defined disorder—Valproic Acid—migraine	0.000104	0.00109	CcSEcCtD
Naratriptan—Angiopathy—Timolol—migraine	0.000104	0.00109	CcSEcCtD
Naratriptan—Pollakiuria—Topiramate—migraine	0.000103	0.00108	CcSEcCtD
Naratriptan—Anaemia—Valproic Acid—migraine	0.000103	0.00108	CcSEcCtD
Naratriptan—Immune system disorder—Timolol—migraine	0.000103	0.00108	CcSEcCtD
Naratriptan—Hypersensitivity—Propranolol—migraine	0.000103	0.00108	CcSEcCtD
Naratriptan—Agitation—Valproic Acid—migraine	0.000103	0.00108	CcSEcCtD
Naratriptan—Urticaria—Verapamil—migraine	0.000102	0.00107	CcSEcCtD
Naratriptan—Photosensitivity reaction—Topiramate—migraine	0.000102	0.00107	CcSEcCtD
Naratriptan—Arrhythmia—Timolol—migraine	0.000102	0.00107	CcSEcCtD
Naratriptan—Nausea—Amitriptyline—migraine	0.000102	0.00107	CcSEcCtD
Naratriptan—Alopecia—Timolol—migraine	0.000101	0.00106	CcSEcCtD
Naratriptan—Hyperglycaemia—Topiramate—migraine	0.000101	0.00106	CcSEcCtD
Naratriptan—Malaise—Valproic Acid—migraine	0.000101	0.00106	CcSEcCtD
Naratriptan—Vertigo—Valproic Acid—migraine	0.000101	0.00105	CcSEcCtD
Naratriptan—Asthenia—Propranolol—migraine	0.0001	0.00105	CcSEcCtD
Naratriptan—Pneumonia—Topiramate—migraine	0.0001	0.00105	CcSEcCtD
Naratriptan—Erythema—Timolol—migraine	9.96e-05	0.00104	CcSEcCtD
Naratriptan—Depression—Topiramate—migraine	9.96e-05	0.00104	CcSEcCtD
Naratriptan—Tinnitus—Gabapentin—migraine	9.93e-05	0.00104	CcSEcCtD
Naratriptan—Cardiac disorder—Gabapentin—migraine	9.89e-05	0.00104	CcSEcCtD
Naratriptan—Palpitations—Valproic Acid—migraine	9.89e-05	0.00104	CcSEcCtD
Naratriptan—Neuropathy peripheral—Topiramate—migraine	9.79e-05	0.00103	CcSEcCtD
Naratriptan—Cough—Valproic Acid—migraine	9.76e-05	0.00102	CcSEcCtD
Naratriptan—Immune system disorder—Gabapentin—migraine	9.62e-05	0.00101	CcSEcCtD
Naratriptan—Diarrhoea—Propranolol—migraine	9.58e-05	0.001	CcSEcCtD
Naratriptan—Chills—Gabapentin—migraine	9.56e-05	0.001	CcSEcCtD
Naratriptan—Myalgia—Valproic Acid—migraine	9.53e-05	0.000998	CcSEcCtD
Naratriptan—Arthralgia—Valproic Acid—migraine	9.53e-05	0.000998	CcSEcCtD
Naratriptan—Anxiety—Valproic Acid—migraine	9.49e-05	0.000995	CcSEcCtD
Naratriptan—Hypersensitivity—Verapamil—migraine	9.49e-05	0.000995	CcSEcCtD
Naratriptan—Alopecia—Gabapentin—migraine	9.42e-05	0.000987	CcSEcCtD
Naratriptan—Discomfort—Valproic Acid—migraine	9.41e-05	0.000987	CcSEcCtD
Naratriptan—Vision blurred—Timolol—migraine	9.39e-05	0.000984	CcSEcCtD
Naratriptan—Sinusitis—Topiramate—migraine	9.37e-05	0.000982	CcSEcCtD
Naratriptan—Dry mouth—Valproic Acid—migraine	9.32e-05	0.000977	CcSEcCtD
Naratriptan—Erythema—Gabapentin—migraine	9.28e-05	0.000972	CcSEcCtD
Naratriptan—Dizziness—Propranolol—migraine	9.26e-05	0.00097	CcSEcCtD
Naratriptan—Asthenia—Verapamil—migraine	9.24e-05	0.000969	CcSEcCtD
Naratriptan—Confusional state—Valproic Acid—migraine	9.21e-05	0.000965	CcSEcCtD
Naratriptan—Oedema—Valproic Acid—migraine	9.13e-05	0.000957	CcSEcCtD
Naratriptan—Anaphylactic shock—Valproic Acid—migraine	9.13e-05	0.000957	CcSEcCtD
Naratriptan—Bradycardia—Topiramate—migraine	9.13e-05	0.000957	CcSEcCtD
Naratriptan—Pruritus—Verapamil—migraine	9.11e-05	0.000955	CcSEcCtD
Naratriptan—Infection—Valproic Acid—migraine	9.07e-05	0.000951	CcSEcCtD
Naratriptan—Haemoglobin—Topiramate—migraine	9.01e-05	0.000944	CcSEcCtD
Naratriptan—Haemorrhage—Topiramate—migraine	8.96e-05	0.00094	CcSEcCtD
Naratriptan—Nervous system disorder—Valproic Acid—migraine	8.96e-05	0.000939	CcSEcCtD
Naratriptan—Vertigo—Timolol—migraine	8.95e-05	0.000938	CcSEcCtD
Naratriptan—Thrombocytopenia—Valproic Acid—migraine	8.94e-05	0.000937	CcSEcCtD
Naratriptan—Syncope—Timolol—migraine	8.93e-05	0.000936	CcSEcCtD
Naratriptan—Hypoaesthesia—Topiramate—migraine	8.92e-05	0.000935	CcSEcCtD
Naratriptan—Hallucination—Topiramate—migraine	8.92e-05	0.000935	CcSEcCtD
Naratriptan—Muscle spasms—Gabapentin—migraine	8.92e-05	0.000935	CcSEcCtD
Naratriptan—Vomiting—Propranolol—migraine	8.9e-05	0.000933	CcSEcCtD
Naratriptan—Skin disorder—Valproic Acid—migraine	8.87e-05	0.00093	CcSEcCtD
Naratriptan—Hyperhidrosis—Valproic Acid—migraine	8.83e-05	0.000925	CcSEcCtD
Naratriptan—Rash—Propranolol—migraine	8.83e-05	0.000925	CcSEcCtD
Naratriptan—Dermatitis—Propranolol—migraine	8.82e-05	0.000924	CcSEcCtD
Naratriptan—Diarrhoea—Verapamil—migraine	8.81e-05	0.000924	CcSEcCtD
Naratriptan—Palpitations—Timolol—migraine	8.8e-05	0.000923	CcSEcCtD
Naratriptan—HTR1B—GPCR ligand binding—HTR2B—migraine	8.77e-05	0.00117	CbGpPWpGaD
Naratriptan—Loss of consciousness—Timolol—migraine	8.75e-05	0.000918	CcSEcCtD
Naratriptan—Vision blurred—Gabapentin—migraine	8.74e-05	0.000916	CcSEcCtD
Naratriptan—Cough—Timolol—migraine	8.69e-05	0.000911	CcSEcCtD
Naratriptan—Tremor—Gabapentin—migraine	8.69e-05	0.000911	CcSEcCtD
Naratriptan—HTR1F—GPCR ligand binding—TAC1—migraine	8.65e-05	0.00115	CbGpPWpGaD
Naratriptan—HTR1F—GPCR ligand binding—NPS—migraine	8.65e-05	0.00115	CbGpPWpGaD
Naratriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	8.61e-05	0.00115	CbGpPWpGaD
Naratriptan—Ill-defined disorder—Gabapentin—migraine	8.61e-05	0.000902	CcSEcCtD
Naratriptan—Anaemia—Gabapentin—migraine	8.57e-05	0.000899	CcSEcCtD
Naratriptan—Hypotension—Valproic Acid—migraine	8.53e-05	0.000894	CcSEcCtD
Naratriptan—Agitation—Gabapentin—migraine	8.52e-05	0.000893	CcSEcCtD
Naratriptan—Dizziness—Verapamil—migraine	8.52e-05	0.000893	CcSEcCtD
Naratriptan—HTR1F—GPCR downstream signaling—HTR1D—migraine	8.51e-05	0.00113	CbGpPWpGaD
Naratriptan—HTR1F—GPCR ligand binding—HTR2C—migraine	8.49e-05	0.00113	CbGpPWpGaD
Naratriptan—Arthralgia—Timolol—migraine	8.48e-05	0.000889	CcSEcCtD
Naratriptan—Myalgia—Timolol—migraine	8.48e-05	0.000889	CcSEcCtD
Naratriptan—Anxiety—Timolol—migraine	8.45e-05	0.000886	CcSEcCtD
Naratriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	8.43e-05	0.00112	CbGpPWpGaD
Naratriptan—Discomfort—Timolol—migraine	8.38e-05	0.000878	CcSEcCtD
Naratriptan—Malaise—Gabapentin—migraine	8.36e-05	0.000877	CcSEcCtD
Naratriptan—Tinnitus—Topiramate—migraine	8.36e-05	0.000876	CcSEcCtD
Naratriptan—Vertigo—Gabapentin—migraine	8.33e-05	0.000874	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Valproic Acid—migraine	8.32e-05	0.000872	CcSEcCtD
Naratriptan—Cardiac disorder—Topiramate—migraine	8.32e-05	0.000872	CcSEcCtD
Naratriptan—Syncope—Gabapentin—migraine	8.32e-05	0.000872	CcSEcCtD
Naratriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	8.32e-05	0.00111	CbGpPWpGaD
Naratriptan—Nausea—Propranolol—migraine	8.32e-05	0.000872	CcSEcCtD
Naratriptan—Dry mouth—Timolol—migraine	8.29e-05	0.000869	CcSEcCtD
Naratriptan—HTR1F—GPCR ligand binding—EDNRA—migraine	8.26e-05	0.0011	CbGpPWpGaD
Naratriptan—Paraesthesia—Valproic Acid—migraine	8.2e-05	0.000859	CcSEcCtD
Naratriptan—Palpitations—Gabapentin—migraine	8.2e-05	0.000859	CcSEcCtD
Naratriptan—Confusional state—Timolol—migraine	8.2e-05	0.000859	CcSEcCtD
Naratriptan—Vomiting—Verapamil—migraine	8.19e-05	0.000858	CcSEcCtD
Naratriptan—Loss of consciousness—Gabapentin—migraine	8.15e-05	0.000855	CcSEcCtD
Naratriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	8.14e-05	0.00109	CbGpPWpGaD
Naratriptan—Dyspnoea—Valproic Acid—migraine	8.14e-05	0.000853	CcSEcCtD
Naratriptan—Angiopathy—Topiramate—migraine	8.13e-05	0.000853	CcSEcCtD
Naratriptan—Anaphylactic shock—Timolol—migraine	8.13e-05	0.000852	CcSEcCtD
Naratriptan—Oedema—Timolol—migraine	8.13e-05	0.000852	CcSEcCtD
Naratriptan—Rash—Verapamil—migraine	8.12e-05	0.000851	CcSEcCtD
Naratriptan—Somnolence—Valproic Acid—migraine	8.12e-05	0.000851	CcSEcCtD
Naratriptan—Dermatitis—Verapamil—migraine	8.11e-05	0.00085	CcSEcCtD
Naratriptan—Immune system disorder—Topiramate—migraine	8.1e-05	0.000849	CcSEcCtD
Naratriptan—Cough—Gabapentin—migraine	8.09e-05	0.000848	CcSEcCtD
Naratriptan—HTR1D—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	8.09e-05	0.00108	CbGpPWpGaD
Naratriptan—Infection—Timolol—migraine	8.08e-05	0.000847	CcSEcCtD
Naratriptan—Headache—Verapamil—migraine	8.07e-05	0.000846	CcSEcCtD
Naratriptan—Chills—Topiramate—migraine	8.04e-05	0.000843	CcSEcCtD
Naratriptan—Convulsion—Gabapentin—migraine	8.04e-05	0.000842	CcSEcCtD
Naratriptan—Shock—Timolol—migraine	8e-05	0.000838	CcSEcCtD
Naratriptan—HTR1F—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	7.98e-05	0.00106	CbGpPWpGaD
Naratriptan—Nervous system disorder—Timolol—migraine	7.97e-05	0.000836	CcSEcCtD
Naratriptan—HTR1F—GPCR ligand binding—CALCA—migraine	7.95e-05	0.00106	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—BDNF—migraine	7.93e-05	0.00106	CbGpPWpGaD
Naratriptan—HTR1B—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	7.92e-05	0.00106	CbGpPWpGaD
Naratriptan—Alopecia—Topiramate—migraine	7.92e-05	0.00083	CcSEcCtD
Naratriptan—HTR1F—GPCR downstream signaling—HTR2B—migraine	7.92e-05	0.00106	CbGpPWpGaD
Naratriptan—Arthralgia—Gabapentin—migraine	7.9e-05	0.000828	CcSEcCtD
Naratriptan—Myalgia—Gabapentin—migraine	7.9e-05	0.000828	CcSEcCtD
Naratriptan—Skin disorder—Timolol—migraine	7.9e-05	0.000828	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Valproic Acid—migraine	7.88e-05	0.000826	CcSEcCtD
Naratriptan—Fatigue—Valproic Acid—migraine	7.87e-05	0.000825	CcSEcCtD
Naratriptan—Anxiety—Gabapentin—migraine	7.87e-05	0.000825	CcSEcCtD
Naratriptan—Hyperhidrosis—Timolol—migraine	7.86e-05	0.000824	CcSEcCtD
Naratriptan—Pain—Valproic Acid—migraine	7.81e-05	0.000819	CcSEcCtD
Naratriptan—Constipation—Valproic Acid—migraine	7.81e-05	0.000819	CcSEcCtD
Naratriptan—Erythema—Topiramate—migraine	7.8e-05	0.000818	CcSEcCtD
Naratriptan—Discomfort—Gabapentin—migraine	7.8e-05	0.000818	CcSEcCtD
Naratriptan—HTR1F—Signaling by GPCR—HTR1D—migraine	7.73e-05	0.00103	CbGpPWpGaD
Naratriptan—Dry mouth—Gabapentin—migraine	7.72e-05	0.00081	CcSEcCtD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	7.67e-05	0.00102	CbGpPWpGaD
Naratriptan—Nausea—Verapamil—migraine	7.65e-05	0.000802	CcSEcCtD
Naratriptan—Confusional state—Gabapentin—migraine	7.63e-05	0.0008	CcSEcCtD
Naratriptan—Hypotension—Timolol—migraine	7.6e-05	0.000796	CcSEcCtD
Naratriptan—Oedema—Gabapentin—migraine	7.57e-05	0.000793	CcSEcCtD
Naratriptan—Anaphylactic shock—Gabapentin—migraine	7.57e-05	0.000793	CcSEcCtD
Naratriptan—Feeling abnormal—Valproic Acid—migraine	7.52e-05	0.000789	CcSEcCtD
Naratriptan—Infection—Gabapentin—migraine	7.52e-05	0.000788	CcSEcCtD
Naratriptan—Muscle spasms—Topiramate—migraine	7.5e-05	0.000786	CcSEcCtD
Naratriptan—HTR1D—GPCR downstream signaling—CALCRL—migraine	7.49e-05	0.000999	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—RAMP1—migraine	7.49e-05	0.000999	CbGpPWpGaD
Naratriptan—Shock—Gabapentin—migraine	7.45e-05	0.000781	CcSEcCtD
Naratriptan—HTR1F—GPCR ligand binding—HTR7—migraine	7.43e-05	0.000991	CbGpPWpGaD
Naratriptan—Nervous system disorder—Gabapentin—migraine	7.42e-05	0.000778	CcSEcCtD
Naratriptan—Thrombocytopenia—Gabapentin—migraine	7.41e-05	0.000777	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Timolol—migraine	7.41e-05	0.000776	CcSEcCtD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	7.38e-05	0.000984	CbGpPWpGaD
Naratriptan—Vision blurred—Topiramate—migraine	7.35e-05	0.000771	CcSEcCtD
Naratriptan—Skin disorder—Gabapentin—migraine	7.35e-05	0.000771	CcSEcCtD
Naratriptan—HTR1B—GPCR downstream signaling—RAMP1—migraine	7.34e-05	0.000978	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—CALCRL—migraine	7.34e-05	0.000978	CbGpPWpGaD
Naratriptan—Hyperhidrosis—Gabapentin—migraine	7.32e-05	0.000767	CcSEcCtD
Naratriptan—Tremor—Topiramate—migraine	7.31e-05	0.000766	CcSEcCtD
Naratriptan—Paraesthesia—Timolol—migraine	7.3e-05	0.000765	CcSEcCtD
Naratriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HTR7—migraine	7.29e-05	0.000971	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	7.27e-05	0.000969	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	7.27e-05	0.000969	CbGpPWpGaD
Naratriptan—Urticaria—Valproic Acid—migraine	7.25e-05	0.00076	CcSEcCtD
Naratriptan—Dyspnoea—Timolol—migraine	7.25e-05	0.00076	CcSEcCtD
Naratriptan—Ill-defined disorder—Topiramate—migraine	7.24e-05	0.000759	CcSEcCtD
Naratriptan—Somnolence—Timolol—migraine	7.23e-05	0.000758	CcSEcCtD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	7.23e-05	0.000963	CbGpPWpGaD
Naratriptan—Body temperature increased—Valproic Acid—migraine	7.22e-05	0.000757	CcSEcCtD
Naratriptan—Anaemia—Topiramate—migraine	7.21e-05	0.000756	CcSEcCtD
Naratriptan—HTR1A—G alpha (i) signalling events—HTR1B—migraine	7.19e-05	0.000959	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—HTR2B—migraine	7.19e-05	0.000958	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—HTR1D—migraine	7.19e-05	0.000958	CbGpPWpGaD
Naratriptan—Agitation—Topiramate—migraine	7.17e-05	0.000752	CcSEcCtD
Naratriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HTR7—migraine	7.13e-05	0.000951	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	7.13e-05	0.00095	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	7.12e-05	0.000948	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	7.12e-05	0.000948	CbGpPWpGaD
Naratriptan—Hypotension—Gabapentin—migraine	7.07e-05	0.000741	CcSEcCtD
Naratriptan—Malaise—Topiramate—migraine	7.04e-05	0.000738	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Timolol—migraine	7.02e-05	0.000736	CcSEcCtD
Naratriptan—Vertigo—Topiramate—migraine	7.01e-05	0.000735	CcSEcCtD
Naratriptan—Fatigue—Timolol—migraine	7.01e-05	0.000735	CcSEcCtD
Naratriptan—Syncope—Topiramate—migraine	7e-05	0.000734	CcSEcCtD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	6.98e-05	0.00093	CbGpPWpGaD
Naratriptan—Pain—Timolol—migraine	6.95e-05	0.000729	CcSEcCtD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	6.93e-05	0.000924	CbGpPWpGaD
Naratriptan—Musculoskeletal discomfort—Gabapentin—migraine	6.9e-05	0.000723	CcSEcCtD
Naratriptan—Palpitations—Topiramate—migraine	6.9e-05	0.000723	CcSEcCtD
Naratriptan—Loss of consciousness—Topiramate—migraine	6.86e-05	0.000719	CcSEcCtD
Naratriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	6.84e-05	0.000911	CbGpPWpGaD
Naratriptan—Cough—Topiramate—migraine	6.81e-05	0.000714	CcSEcCtD
Naratriptan—HTR1D—Signaling by GPCR—CALCRL—migraine	6.81e-05	0.000907	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—RAMP1—migraine	6.81e-05	0.000907	CbGpPWpGaD
Naratriptan—Paraesthesia—Gabapentin—migraine	6.8e-05	0.000713	CcSEcCtD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	6.79e-05	0.000905	CbGpPWpGaD
Naratriptan—Convulsion—Topiramate—migraine	6.76e-05	0.000709	CcSEcCtD
Naratriptan—Dyspnoea—Gabapentin—migraine	6.75e-05	0.000707	CcSEcCtD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—BDNF—migraine	6.74e-05	0.000898	CbGpPWpGaD
Naratriptan—Somnolence—Gabapentin—migraine	6.73e-05	0.000705	CcSEcCtD
Naratriptan—Hypersensitivity—Valproic Acid—migraine	6.73e-05	0.000705	CcSEcCtD
Naratriptan—Feeling abnormal—Timolol—migraine	6.7e-05	0.000702	CcSEcCtD
Naratriptan—MAOA—SIDS Susceptibility Pathways—HTR2A—migraine	6.7e-05	0.000893	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—HTR2B—migraine	6.68e-05	0.000891	CbGpPWpGaD
Naratriptan—HTR1A—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	6.67e-05	0.00089	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CALCRL—migraine	6.66e-05	0.000888	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—RAMP1—migraine	6.66e-05	0.000888	CbGpPWpGaD
Naratriptan—Arthralgia—Topiramate—migraine	6.64e-05	0.000696	CcSEcCtD
Naratriptan—Myalgia—Topiramate—migraine	6.64e-05	0.000696	CcSEcCtD
Naratriptan—Anxiety—Topiramate—migraine	6.62e-05	0.000694	CcSEcCtD
Naratriptan—Discomfort—Topiramate—migraine	6.56e-05	0.000688	CcSEcCtD
Naratriptan—Asthenia—Valproic Acid—migraine	6.55e-05	0.000687	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Gabapentin—migraine	6.54e-05	0.000685	CcSEcCtD
Naratriptan—Fatigue—Gabapentin—migraine	6.53e-05	0.000684	CcSEcCtD
Naratriptan—Dry mouth—Topiramate—migraine	6.5e-05	0.000681	CcSEcCtD
Naratriptan—Pain—Gabapentin—migraine	6.47e-05	0.000679	CcSEcCtD
Naratriptan—Constipation—Gabapentin—migraine	6.47e-05	0.000679	CcSEcCtD
Naratriptan—Pruritus—Valproic Acid—migraine	6.46e-05	0.000677	CcSEcCtD
Naratriptan—Urticaria—Timolol—migraine	6.46e-05	0.000677	CcSEcCtD
Naratriptan—Body temperature increased—Timolol—migraine	6.43e-05	0.000674	CcSEcCtD
Naratriptan—Confusional state—Topiramate—migraine	6.42e-05	0.000673	CcSEcCtD
Naratriptan—Oedema—Topiramate—migraine	6.37e-05	0.000668	CcSEcCtD
Naratriptan—Infection—Topiramate—migraine	6.33e-05	0.000663	CcSEcCtD
Naratriptan—HTR1F—Signaling Pathways—RAMP1—migraine	6.29e-05	0.000838	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CALCRL—migraine	6.29e-05	0.000838	CbGpPWpGaD
Naratriptan—Shock—Topiramate—migraine	6.27e-05	0.000657	CcSEcCtD
Naratriptan—Diarrhoea—Valproic Acid—migraine	6.25e-05	0.000655	CcSEcCtD
Naratriptan—Nervous system disorder—Topiramate—migraine	6.25e-05	0.000655	CcSEcCtD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	6.24e-05	0.000832	CbGpPWpGaD
Naratriptan—Feeling abnormal—Gabapentin—migraine	6.24e-05	0.000654	CcSEcCtD
Naratriptan—Thrombocytopenia—Topiramate—migraine	6.24e-05	0.000654	CcSEcCtD
Naratriptan—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	6.2e-05	0.000827	CbGpPWpGaD
Naratriptan—Skin disorder—Topiramate—migraine	6.19e-05	0.000648	CcSEcCtD
Naratriptan—Hyperhidrosis—Topiramate—migraine	6.16e-05	0.000645	CcSEcCtD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	6.11e-05	0.000815	CbGpPWpGaD
Naratriptan—Dizziness—Valproic Acid—migraine	6.04e-05	0.000633	CcSEcCtD
Naratriptan—HTR1A—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	6.04e-05	0.000804	CbGpPWpGaD
Naratriptan—Urticaria—Gabapentin—migraine	6.01e-05	0.00063	CcSEcCtD
Naratriptan—Hypersensitivity—Timolol—migraine	5.99e-05	0.000628	CcSEcCtD
Naratriptan—Body temperature increased—Gabapentin—migraine	5.98e-05	0.000627	CcSEcCtD
Naratriptan—Hypotension—Topiramate—migraine	5.95e-05	0.000624	CcSEcCtD
Naratriptan—HTR1D—GPCR ligand binding—HTR1B—migraine	5.84e-05	0.000778	CbGpPWpGaD
Naratriptan—Asthenia—Timolol—migraine	5.83e-05	0.000611	CcSEcCtD
Naratriptan—Vomiting—Valproic Acid—migraine	5.81e-05	0.000609	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Topiramate—migraine	5.8e-05	0.000608	CcSEcCtD
Naratriptan—Rash—Valproic Acid—migraine	5.76e-05	0.000604	CcSEcCtD
Naratriptan—Dermatitis—Valproic Acid—migraine	5.75e-05	0.000603	CcSEcCtD
Naratriptan—Pruritus—Timolol—migraine	5.75e-05	0.000603	CcSEcCtD
Naratriptan—Headache—Valproic Acid—migraine	5.72e-05	0.0006	CcSEcCtD
Naratriptan—Paraesthesia—Topiramate—migraine	5.72e-05	0.000599	CcSEcCtD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	5.72e-05	0.000762	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—HTR2A—migraine	5.69e-05	0.000759	CbGpPWpGaD
Naratriptan—Dyspnoea—Topiramate—migraine	5.68e-05	0.000595	CcSEcCtD
Naratriptan—Somnolence—Topiramate—migraine	5.66e-05	0.000593	CcSEcCtD
Naratriptan—HTR1D—GPCR ligand binding—HTR1A—migraine	5.62e-05	0.000749	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—RAMP1—migraine	5.59e-05	0.000745	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CALCRL—migraine	5.59e-05	0.000745	CbGpPWpGaD
Naratriptan—Hypersensitivity—Gabapentin—migraine	5.58e-05	0.000585	CcSEcCtD
Naratriptan—Diarrhoea—Timolol—migraine	5.56e-05	0.000583	CcSEcCtD
Naratriptan—HTR1D—GPCR ligand binding—TAC1—migraine	5.53e-05	0.000738	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—NPS—migraine	5.53e-05	0.000738	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—HTR1A—migraine	5.5e-05	0.000733	CbGpPWpGaD
Naratriptan—Gastrointestinal disorder—Topiramate—migraine	5.5e-05	0.000576	CcSEcCtD
Naratriptan—Fatigue—Topiramate—migraine	5.49e-05	0.000576	CcSEcCtD
Naratriptan—Pain—Topiramate—migraine	5.45e-05	0.000571	CcSEcCtD
Naratriptan—Constipation—Topiramate—migraine	5.45e-05	0.000571	CcSEcCtD
Naratriptan—HTR1A—GPCRs, Class A Rhodopsin-like—HTR7—migraine	5.43e-05	0.000724	CbGpPWpGaD
Naratriptan—Asthenia—Gabapentin—migraine	5.43e-05	0.000569	CcSEcCtD
Naratriptan—HTR1D—GPCR ligand binding—HTR2C—migraine	5.43e-05	0.000723	CbGpPWpGaD
Naratriptan—Nausea—Valproic Acid—migraine	5.42e-05	0.000569	CcSEcCtD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	5.42e-05	0.000722	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	5.42e-05	0.000722	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—NPS—migraine	5.42e-05	0.000722	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—TAC1—migraine	5.42e-05	0.000722	CbGpPWpGaD
Naratriptan—Dizziness—Timolol—migraine	5.38e-05	0.000563	CcSEcCtD
Naratriptan—Pruritus—Gabapentin—migraine	5.36e-05	0.000561	CcSEcCtD
Naratriptan—HTR1B—GPCR downstream signaling—HTR1D—migraine	5.33e-05	0.000711	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	5.32e-05	0.000709	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—HTR2C—migraine	5.31e-05	0.000708	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—EDNRA—migraine	5.28e-05	0.000704	CbGpPWpGaD
Naratriptan—Feeling abnormal—Topiramate—migraine	5.25e-05	0.00055	CcSEcCtD
Naratriptan—HTR1F—GPCR ligand binding—HTR2A—migraine	5.21e-05	0.000694	CbGpPWpGaD
Naratriptan—Diarrhoea—Gabapentin—migraine	5.18e-05	0.000543	CcSEcCtD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	5.17e-05	0.000689	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—EDNRA—migraine	5.17e-05	0.000689	CbGpPWpGaD
Naratriptan—Vomiting—Timolol—migraine	5.17e-05	0.000542	CcSEcCtD
Naratriptan—HTR1F—GPCR downstream signaling—HTR1B—migraine	5.16e-05	0.000688	CbGpPWpGaD
Naratriptan—Rash—Timolol—migraine	5.13e-05	0.000537	CcSEcCtD
Naratriptan—Dermatitis—Timolol—migraine	5.12e-05	0.000537	CcSEcCtD
Naratriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	5.1e-05	0.00068	CbGpPWpGaD
Naratriptan—Headache—Timolol—migraine	5.09e-05	0.000534	CcSEcCtD
Naratriptan—HTR1D—GPCR ligand binding—CALCA—migraine	5.08e-05	0.000677	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CALCRL—migraine	5.08e-05	0.000677	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—RAMP1—migraine	5.08e-05	0.000677	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—HTR2B—migraine	5.06e-05	0.000675	CbGpPWpGaD
Naratriptan—Urticaria—Topiramate—migraine	5.06e-05	0.00053	CcSEcCtD
Naratriptan—Body temperature increased—Topiramate—migraine	5.03e-05	0.000528	CcSEcCtD
Naratriptan—Dizziness—Gabapentin—migraine	5.01e-05	0.000525	CcSEcCtD
Naratriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	5e-05	0.000666	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—CALCA—migraine	4.98e-05	0.000663	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—HTR1A—migraine	4.97e-05	0.000662	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—HTR2B—migraine	4.96e-05	0.000661	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—NPS—migraine	4.89e-05	0.000652	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—TAC1—migraine	4.89e-05	0.000652	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—HTR1D—migraine	4.84e-05	0.000645	CbGpPWpGaD
Naratriptan—Nausea—Timolol—migraine	4.83e-05	0.000506	CcSEcCtD
Naratriptan—Vomiting—Gabapentin—migraine	4.81e-05	0.000505	CcSEcCtD
Naratriptan—HTR1F—GPCR downstream signaling—HTR2C—migraine	4.8e-05	0.000639	CbGpPWpGaD
Naratriptan—Rash—Gabapentin—migraine	4.77e-05	0.0005	CcSEcCtD
Naratriptan—Dermatitis—Gabapentin—migraine	4.77e-05	0.0005	CcSEcCtD
Naratriptan—HTR1D—GPCR ligand binding—HTR7—migraine	4.75e-05	0.000634	CbGpPWpGaD
Naratriptan—Headache—Gabapentin—migraine	4.74e-05	0.000497	CcSEcCtD
Naratriptan—Hypersensitivity—Topiramate—migraine	4.69e-05	0.000492	CcSEcCtD
Naratriptan—HTR1F—Signaling by GPCR—HTR1B—migraine	4.68e-05	0.000624	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—EDNRA—migraine	4.67e-05	0.000622	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	4.66e-05	0.000621	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—HTR7—migraine	4.65e-05	0.00062	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—HTR2B—migraine	4.6e-05	0.000613	CbGpPWpGaD
Naratriptan—Asthenia—Topiramate—migraine	4.57e-05	0.000479	CcSEcCtD
Naratriptan—HTR1F—Signaling Pathways—HTR1D—migraine	4.57e-05	0.000609	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—HTR1A—migraine	4.51e-05	0.000601	CbGpPWpGaD
Naratriptan—Pruritus—Topiramate—migraine	4.51e-05	0.000472	CcSEcCtD
Naratriptan—HTR1B—Signaling by GPCR—HTR2B—migraine	4.5e-05	0.0006	CbGpPWpGaD
Naratriptan—Nausea—Gabapentin—migraine	4.5e-05	0.000471	CcSEcCtD
Naratriptan—HTR1F—GPCR downstream signaling—CALCA—migraine	4.49e-05	0.000599	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—NPS—migraine	4.44e-05	0.000592	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—TAC1—migraine	4.44e-05	0.000592	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	4.37e-05	0.000583	CbGpPWpGaD
Naratriptan—Diarrhoea—Topiramate—migraine	4.36e-05	0.000457	CcSEcCtD
Naratriptan—HTR1F—Signaling by GPCR—HTR2C—migraine	4.35e-05	0.00058	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—HTR1B—migraine	4.35e-05	0.00058	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	4.28e-05	0.000571	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HTR2B—migraine	4.25e-05	0.000566	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—EDNRA—migraine	4.24e-05	0.000565	CbGpPWpGaD
Naratriptan—Dizziness—Topiramate—migraine	4.21e-05	0.000441	CcSEcCtD
Naratriptan—HTR1F—GPCR downstream signaling—HTR7—migraine	4.2e-05	0.00056	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—NPS—migraine	4.13e-05	0.00055	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—TAC1—migraine	4.13e-05	0.00055	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—CALCA—migraine	4.08e-05	0.000544	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—HTR1D—migraine	4.06e-05	0.000541	CbGpPWpGaD
Naratriptan—Vomiting—Topiramate—migraine	4.05e-05	0.000424	CcSEcCtD
Naratriptan—HTR1A—GPCR ligand binding—HTR2C—migraine	4.05e-05	0.00054	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—RAMP1—migraine	4.02e-05	0.000536	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CALCRL—migraine	4.02e-05	0.000536	CbGpPWpGaD
Naratriptan—Rash—Topiramate—migraine	4.02e-05	0.000421	CcSEcCtD
Naratriptan—Dermatitis—Topiramate—migraine	4.01e-05	0.000421	CcSEcCtD
Naratriptan—Headache—Topiramate—migraine	3.99e-05	0.000418	CcSEcCtD
Naratriptan—HTR1A—GPCR ligand binding—EDNRA—migraine	3.94e-05	0.000525	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—RAMP1—migraine	3.94e-05	0.000525	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CALCRL—migraine	3.94e-05	0.000525	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—HTR7—migraine	3.81e-05	0.000508	CbGpPWpGaD
Naratriptan—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	3.81e-05	0.000507	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—CALCA—migraine	3.79e-05	0.000505	CbGpPWpGaD
Naratriptan—Nausea—Topiramate—migraine	3.78e-05	0.000397	CcSEcCtD
Naratriptan—HTR1A—GPCR downstream signaling—HTR2B—migraine	3.78e-05	0.000503	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—LRP1—migraine	3.74e-05	0.000498	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—HTR1D—migraine	3.69e-05	0.000492	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—HTR7—migraine	3.55e-05	0.000473	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—HTR2B—migraine	3.43e-05	0.000457	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—HTR2A—migraine	3.33e-05	0.000444	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—HTR1B—migraine	3.3e-05	0.00044	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	3.26e-05	0.000435	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—HTR2A—migraine	3.26e-05	0.000434	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CACNA1A—migraine	3.2e-05	0.000426	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—HTR1A—migraine	3.18e-05	0.000423	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—NPS—migraine	3.13e-05	0.000417	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—TAC1—migraine	3.13e-05	0.000417	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—HTR1A—migraine	3.11e-05	0.000414	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—HTR2C—migraine	3.07e-05	0.000409	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—TAC1—migraine	3.06e-05	0.000408	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—NPS—migraine	3.06e-05	0.000408	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—HTR2C—migraine	3e-05	0.0004	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—RAMP1—migraine	3e-05	0.0004	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CALCRL—migraine	3e-05	0.0004	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—HTR1B—migraine	3e-05	0.000399	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—EDNRA—migraine	2.98e-05	0.000398	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—HTR2A—migraine	2.94e-05	0.000392	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—EDNRA—migraine	2.92e-05	0.000389	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—HTR1A—migraine	2.88e-05	0.000384	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—TNF—migraine	2.88e-05	0.000384	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—CALCA—migraine	2.87e-05	0.000383	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—NOTCH4—migraine	2.87e-05	0.000382	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HTR1D—migraine	2.86e-05	0.000381	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—NPS—migraine	2.84e-05	0.000379	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—TAC1—migraine	2.84e-05	0.000379	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—HTR1A—migraine	2.82e-05	0.000376	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—CALCA—migraine	2.81e-05	0.000375	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—HTR2C—migraine	2.78e-05	0.000371	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—NPS—migraine	2.78e-05	0.000371	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—TAC1—migraine	2.78e-05	0.000371	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HTR1B—migraine	2.77e-05	0.000369	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—HTR2C—migraine	2.73e-05	0.000363	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HTR2B—migraine	2.72e-05	0.000362	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—EDNRA—migraine	2.71e-05	0.000361	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—HTR7—migraine	2.69e-05	0.000358	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—HTR2A—migraine	2.67e-05	0.000356	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HTR1A—migraine	2.66e-05	0.000355	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HTR2B—migraine	2.66e-05	0.000354	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—EDNRA—migraine	2.65e-05	0.000354	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—HTR7—migraine	2.63e-05	0.000351	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TAC1—migraine	2.62e-05	0.00035	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—NPS—migraine	2.62e-05	0.00035	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PGR—migraine	2.62e-05	0.00035	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CALCA—migraine	2.61e-05	0.000348	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HTR2C—migraine	2.57e-05	0.000343	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CALCA—migraine	2.55e-05	0.00034	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—EDNRA—migraine	2.5e-05	0.000334	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—HTR2A—migraine	2.48e-05	0.000331	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—HTR1B—migraine	2.46e-05	0.000328	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—TNF—migraine	2.45e-05	0.000326	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—HTR7—migraine	2.44e-05	0.000325	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—NOTCH3—migraine	2.44e-05	0.000325	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CALCA—migraine	2.41e-05	0.000321	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—LRP1—migraine	2.39e-05	0.000319	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—HTR7—migraine	2.39e-05	0.000318	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—LRP1—migraine	2.34e-05	0.000312	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—TAC1—migraine	2.33e-05	0.000311	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—NPS—migraine	2.33e-05	0.000311	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—HTR2C—migraine	2.29e-05	0.000305	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HTR7—migraine	2.25e-05	0.0003	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—HTR1B—migraine	2.23e-05	0.000298	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—EDNRA—migraine	2.23e-05	0.000297	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HTR1D—migraine	2.18e-05	0.00029	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CALCA—migraine	2.14e-05	0.000286	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—NPS—migraine	2.12e-05	0.000282	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—TAC1—migraine	2.12e-05	0.000282	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—HTR2C—migraine	2.08e-05	0.000277	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HTR2B—migraine	2.03e-05	0.00027	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—EDNRA—migraine	2.02e-05	0.000269	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—HTR7—migraine	2e-05	0.000267	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CALCA—migraine	1.95e-05	0.000259	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TGFBR2—migraine	1.94e-05	0.000259	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—HTR2A—migraine	1.88e-05	0.000251	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—HTR2A—migraine	1.84e-05	0.000246	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NOTCH4—migraine	1.83e-05	0.000244	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—HTR7—migraine	1.82e-05	0.000243	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NOTCH4—migraine	1.8e-05	0.000239	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—LRP1—migraine	1.78e-05	0.000238	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HTR1B—migraine	1.77e-05	0.000236	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—HTR2A—migraine	1.71e-05	0.000228	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HTR1A—migraine	1.7e-05	0.000227	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NPS—migraine	1.68e-05	0.000224	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TAC1—migraine	1.68e-05	0.000224	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PGR—migraine	1.68e-05	0.000224	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—HTR2A—migraine	1.67e-05	0.000223	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HTR1A—migraine	1.67e-05	0.000222	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HTR2C—migraine	1.65e-05	0.000219	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NPS—migraine	1.64e-05	0.000219	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TAC1—migraine	1.64e-05	0.000219	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PGR—migraine	1.64e-05	0.000219	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HTR2C—migraine	1.61e-05	0.000215	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—EDNRA—migraine	1.6e-05	0.000213	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HTR2A—migraine	1.58e-05	0.00021	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—EDNRA—migraine	1.57e-05	0.000209	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NOTCH3—migraine	1.56e-05	0.000208	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CALCA—migraine	1.54e-05	0.000205	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NOTCH3—migraine	1.53e-05	0.000204	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CALCA—migraine	1.51e-05	0.000201	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HTR7—migraine	1.44e-05	0.000192	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HTR7—migraine	1.41e-05	0.000188	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—HTR2A—migraine	1.4e-05	0.000187	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—ESR1—migraine	1.4e-05	0.000187	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NOTCH4—migraine	1.37e-05	0.000182	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HTR1B—migraine	1.32e-05	0.000176	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—HTR2A—migraine	1.27e-05	0.00017	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PGR—migraine	1.25e-05	0.000167	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NPS—migraine	1.25e-05	0.000167	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TAC1—migraine	1.25e-05	0.000167	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TGFBR2—migraine	1.24e-05	0.000165	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HTR2C—migraine	1.23e-05	0.000164	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TGFBR2—migraine	1.22e-05	0.000162	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—EDNRA—migraine	1.19e-05	0.000159	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NOTCH3—migraine	1.16e-05	0.000155	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CALCA—migraine	1.15e-05	0.000153	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HTR7—migraine	1.07e-05	0.000143	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—MTHFR—migraine	1.06e-05	0.000141	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HTR2A—migraine	1.01e-05	0.000135	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HTR2A—migraine	9.88e-06	0.000132	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TGFBR2—migraine	9.26e-06	0.000123	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—ESR1—migraine	8.96e-06	0.000119	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—ESR1—migraine	8.77e-06	0.000117	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HTR2A—migraine	7.53e-06	0.0001	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ESR1—migraine	6.68e-06	8.91e-05	CbGpPWpGaD
